Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve Medicamen Biotech Limited has informed that meeting of the Board of Directors of the Company is scheduled on 30.05.2025, inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the financial year ended on 31.03.2025 and to consider recommending payment of dividend to the shareholders.